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Compared to proteins and RNAs, functional specificities associated with structural variations in fatty acids and lipids have 
been greatly underexplored. This review describes how our lab naively started to work on lipids 14 years ago, and how we 
have gradually overcome obstacles to address some interesting biological questions by combining genetics with biochemical 
methods on the nematode Caenorhabditis elegans. Our studies have revealed lipid variants and their metabolic pathways, in 
specific tissues, impact development and behaviors by regulating specific signaling events. The review also discusses the gen-
eral research approach, style of lab management, and funding mechanisms that have facilitated the frequent research direction 
changes in the lab, including the journey into the lipid field. 
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1  The “bad” habit of shifting research direc-
tions 
It is not uncommon for laboratories that use genetic model 
organisms to often move to or add research directions to 
address questions in fields outside their expertise. Over a 
long period of time, these labs would have studied problems 
in a fairly broad range of biological fields. There are per-
haps two major reasons that drive such research dynamics 
in these labs. First, genetic screens and analyses of muta-
tions following specific developmental/behavioral problems 
often lead investigators to address mechanism questions in 
different fields (e.g., signal transduction pathway, gene ex-
pression regulation, vesicle trafficking.). In addition, genetic 
screens often reveal mutants with somewhat surprising 
phenotypes that raise interesting questions and open new 
research directions. Second, many investigators understand 
that model organisms, especially non-vertebrate organisms 
such as worms and flies, are best used to understand basic 
mechanisms underlying fundamental biological processes. 
In other words, using these model organisms to address new 
problems in under-explored research areas may provide 
better opportunities to identify new paradigms that would 
apply to mammals or humans. In addition, these organisms 
are not advantageous compared to cell culture systems when 
biochemical analyses are the dominant approaches used to 
answer detailed mechanistic questions.  
These two reasons are surely the ones to blame for the 
unusually broad scope of research in my lab over the past 
24 years. In the early 1990s, we were mostly focused on, 
and having great time, dissecting the Ras signaling pathway 
in controlling Caenorhabditis elegans development, riding 
on a large number of suppressor/enhancer mutations from 
several modifier screens (e.g., [1–6]). However, thinking 
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that the pathway would soon be worked out at the level we 
could handle, in the mid-1990s we started to shift attention 
to cellular events that occurred downstream of the signaling 
transduction events. In fact, while my first National Institute 
of Health (NIH) R01 grant, started in 1992, focused on ge-
netic screens and analyses of factors regulating the Ras sig-
naling pathway, the renewal application submitted in 1996 
already proposed to study vulval morphogenesis. Several of 
the new research directions that attracted much of the lab’s 
efforts for many years were spin-offs of interesting mutants 
isolated during the studies of cell signaling and morpho-
genesis for vulval development. In some cases, it was very 
much by serendipity, but embraced by students or postdoc-
toral fellows who had the noses to sense important and un-
answered questions. For example, Chris Malone, a new 
graduate student in 1994, analyzed a mutation “incorrectly” 
isolated in the lab as a suppressor of activated Ras. After he 
determined that this was really an allele of the unc-83 gene 
with a nuclear migration defect, he decided to work on nu-
clear positioning for his Ph.D. thesis (collaboration with 
Robert Horvitz lab at Massachusetts Institute of Technology). 
His effort led to the publication of a groundbreaking paper 
that defined the SUN protein family at the nuclear envelope 
and their roles on nuclear migration and anchorage [7]. Later, 
Dan Starr’s work on two other related genes led to his pro-
posal of KASH domain proteins and the universal pairing 
between SUN and KASH proteins at the nuclear envelope 
for various cellular functions [8,9]. Both Dan and Chris 
continued to work on these nuclear envelope complexes in 
their own labs. Following these pioneer studies, we were 
able to play a leading role in functional studies on these 
protein complexes including uncovering their roles in  
several important cellular and development processes in 
mice [10–16]; the majority of the mouse genetics were done 
at the Institute of Developmental Biology and Molecular 
Medicine of Fudan University, collaborating with Tian Xu 
(Howard Hughes Medical Institute (HHMI), Yale), Yuan 
Zhuang (Duke) and others.  
Similarly, our extensive efforts on microRNA-related 
research were also initiated by an unexpected discovery. Lei 
Ding, a graduate student, position cloned a novel gene de-
fined by two mutations from a morphology-based genetic 
screen aimed for factors acting downstream of a transcrip-
tion factor. To understand the mechanism of its function, 
Lei decided to take a hardcore biochemical approach and 
discovered the tight interaction of this protein with Argo-
naute proteins and miRNAs. The combination of genetics 
and biochemistry led to a publication that was the first to 
report the essential role of a GW182 family protein in the 
miRNA-induced silencing complex (miRISC) [17]. He also 
showed that it was GW182 that brings miRISCs to specific 
cellular locations for target inhibition. Several researchers in 
the lab have since carried out intelligent systematic analyses 
of miRNA-target interaction networks and functions by pio-
neering cross-linked immunoprecipitation (CLIP) against 
GW128 proteins and doing combinatory genetics  
(e.g., [18–21]). We also enjoyed collaboration with Victor 
Ambros, who discovered miRNA, on two papers on this sub-
ject [22,23].  
In contrast to the above examples, some of the “off track” 
studies in the lab were the consequence of meticulous think-
ing and bold moves. For example, after writing a short review 
on “synthetic multivulva genes” [24], postdoctoral fellow 
David Fay thought that the so called “genetic redundancy by 
structurally unrelated genes” is so widely present, it is per-
haps the biggest obstacle for applying genetics to uncover 
gene functions. He abandoned his two years of effort on vul-
val morphogenesis and designed a new screen that could be 
used to identify developmental functions associated with any 
gene that displays no obvious loss-of-function phenotype in 
development. His 2002 paper described a successful genetic 
screen for mutations that cause “synthetic” phenotypes in 
combination with a mutation in tumor suppressor Rb/lin-35, 
which also identified factors acting with Rb for specific func-
tions [25]. A few years later, Yo Suzuki followed the idea 
and uncovered many developmental functions associated 
with tumor suppressor PTEN/daf-18, albeit using a different 
screen strategy [26]. Both went on to pursue their own inde-
pendent research careers doing things related to genetic re-
dundancy. Cui Mingxue, another postdoctoral fellow, made a 
breakthrough in understanding the functions of Rb and other 
“synthetic multivulva genes”: they repress undesired expres-
sion of a growth factor in the epidermis [27] (collaboration 
with Iva Greenwald and Paul Sternberg). Later, he also 
showed that Rb critically regulates starvation-induced stress 
responses [28].  
More recently, Ben Weaver and Rebecca Zabinsky 
thought that the “genetic redundancy” concept should apply 
very well to miRNA-mediated gene silencing, since studies 
from the labs of Bob Horvitz, Victor Ambros, and others 
have demonstrated that individually mutating the majority of 
miRNAs, or even miRNA families, do not cause obvious 
developmental defects [29,30], and the extent of down-  
regulation of individual target mRNAs by a specific miRNA 
is usually limited [31,32]. Therefore, miRNAs commonly 
affect specific physiological functions by not only silencing 
genes through a complex miRNA-target interaction network, 
but also by sharing functions with other expression regulatory 
mechanisms. Each individual mode of regulation contributes 
to the robustness of gene expression dynamics. With this idea 
in mind, they carried out a genome-wide genetic modifier 
screen to search for factors that collaborate with miRNAs to 
regulate gene expression dynamics needed for robust devel-
opment. This screen, using mutations in the two GW182 
genes, uncovered a large number of interactors. Their efforts 
on one of them, the CED-3 caspase that was extensively 
studies for its role in apoptosis [33], uncovered unexpected 
but widely used non-apoptotic functions of the CED-3 path-
way in repressing gene expression during development [34]. 
The collaborative role of CED-3 and miRNAs in regulating 
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the LIN-28 pluripotency/developmental timing pathway 
was demonstrated at both genetic and biochemical levels. 
This discovery led to another “synthetic phenotype” screen 
to systematically investigate the non-apoptotic roles of 
CED-3 in repressing gene expression for a broad range of 
cellular processes. These findings drove Ben into a new 
research direction, which will serve him well once he be-
comes a PI.   
2  A bold but naïve move to explore the func-
tional consequences of obscure fatty acid vari-
ants 
Perhaps the most dramatic change of research direction in 
our laboratory was the decision in the early 2000s to work 
on lipids, which had no relationship with any of the C. ele-
gans projects in the lab. From 1996–2001, my lab hosted a 
small human genetic project brought in by a friend who had 
just finished his Ph.D. and MD training from Harvard. I 
hired a non-conventional postdoctoral fellow, Marina Kni-
azeva, to work with this ophthalmologist-to-be to map sev-
eral familiar eye disease genes [35–37]. One major outcome 
of this collaborative effort (Merck also stepped in to deter-
mine the DNA lesion) eventually lead to the cloning of an 
autosomal dominant macular dystrophy gene ELOVL-4 that 
encodes a very long chain fatty acid elongation enzyme [38]. 
Wondering why changing the level of certain very 
long-chain fatty acids (VLCFA) would lead to this degener 
ation, Marina searched the literature only to find that essen-
tially nothing was known about functional specificities as-
sociated with VLCFAs. In fact, we realized that functional 
specificities associated with the vast majority of fatty acid 
(FA) variants were essentially unexplored, even though 
sporadic studies have linked FA imbalance to changes  
in cellular processes and human health problems  
(e.g., [39–45]. There are nearly 100 different types of fatty 
acids, varying in (i) their lengths from as short as six car-
bons to more than 30 carbons, (ii) degree of saturation, (iii) 
whether the number of carbons in the main chain is even or 
odd, and (ⅳ) whether they contain one or more branched 
chains (Figure 1). Even though some of these differences 
were understood on some level (e.g. degree of saturation 
impacts the fluidity of lipid bilayers by changing physical 
properties of the lipid), our understanding of the physiolog-
ical functions that resulted from these differences (e.g., the 
difference between omega-3 vs. omega-6 FAs) was actually 
still very limited (Figure 1). Evolution does not select these 
structural variations without needed functional consequenc-
es. The lack of studies on this general subject made it par-
ticularly attractive to Marina and I—we were pleased to see 
this huge knowledge gap in our literature surfing. Marina 
decided that she would use C. elegans genetics, like the rest 
of the researchers in the lab, to study functional specificities 
associated with certain FA variants, leading to the eventual 
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Figure 1 (color online)  Functional specificities associated with structural variants remain largely unclear. Top, schematic illustration of variations in FA 
structures and outstanding functional questions associated with these variations. “?” above the arrows denotes potential regulations involved the processes. 
Specifically, incorporation of specific FAs into certain classes of high-order lipids may be modulated by changes in the levels or activities of certain enzymes 
involved in specific cells/tissues during development, which would in turn alter the composition of lipids in cell membranes (Figure 3 illustrates an example). 
Functional specificities associated with most of the FA variants are unclear. Bottom, three examples of fatty acid structural variants. 
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her exceptional talent, I simply left her alone for such a 
journey and tried to recruit more people to join her. Think-
ing back today, we were actually incredibly naïve about 
working on lipids at the time, but knowing too much would 
probably have served as a giant stop sign for this bold move. 
Unlike proteins and non-coding RNAs, lipid variants 
have no linear relation to the genome, which severely limits 
the power of straightforward genetics to connect the struc-
tural variations to physiological functions. The strength of 
the lab had been the ability to do sophisticated genetic 
analysis, which would help us to deal with the difficulty of 
doing “lipid genetics”, but we had to also be able to apply 
biochemical and genomic tools to characterize lipid and 
gene expression profiles. For example, we were later forced 
to establish our own mass spectrometry for analyzing lipid 
profiles, after failing to form collaborations with several 
lipid experts.   
Assuming that each of the elongation enzymes would 
likely have a certain degree of specificity for different fatty 
acids, Marina first applied RNA interference to eight genes 
that were homologous to the mammalian elongation en-
zymes and examined the FA composition and developmen-
tal defects. She then analyzed the interesting phenotype 
associated with the elo-2 gene more in depth [46]. Her ef-
fort on elo-2 received collaborative help from Jenny Watts 
at Washington State University, who pioneered studies on 
FA biosynthesis and functions in C. elegans [47].  
Among the eight elo- genes, elo-5 was the most attractive 
one because knocking it down generated the most specific 
change in FA composition, deficiency in monomethyl 
branched-chain fatty acids (mmBCFAs), and prominent 
developmental defects [48]. These observations would po-
tentially allow us to uncover physiological functions specif-
ically associated with one type of fatty acid. Excitingly, 
Marina soon found that feeding worms with a chemical 
synthesized mmBCFA (C17iso) could totally overcome the 
defect that resulted from elo-5(RNAi) or an elo-5(-) deletion 
mutation, meaning that lack of this specific fatty acid was 
the main cause of the developmental defects.  
What did we know about mmBCFAs in animals? From 
the literature we recognized: (i) mmBCFAs are abundantly 
present in mammals including humans, as we not only eat a 
lot of them in dairy products and meat but also synthesize 
them through a de novo pathway that had not yet been re-
vealed in metazoans [49–55]; and (ii) the functions of 
mmBCFAs in animals had been essentially unexplored. 
These two facts further enhanced our interest in using 
mmBCFA as a “model system” in C. elegans to study the 
functions associated with special FA variants and the 
mechanisms underlying the functions.  
In 2004, we had done a basic characterization of 
mmBCFAs in C. elegans, which included: identifying some 
key components of the mmBCFA de novo synthesis path-
way, showing their essential roles in postembryonic devel-
opment, investigating the impact of mmBCFA deficiency 
on gene expression and FA metabolism, and identifying 
genes potentially involved in regulating mmBCFA homeo-
stasis [48]. In particular, we observed that depleting 
mmBCFAs in the embryo caused the worms to arrest their 
postembryonic growth and development and such arrest can 
be reversed by dietary supplementation of mmBCFAs. We 
decided to submit this long paper to the newly established 
open-access journal PLoS Biology, for which I had joined a 
group to voice the support. If “impact factor” would be con-
sidered the only measuring stick for the success of this new 
journal, we had certainly done them a terrible disservice, as 
the two-year post publication citation of this paper was zero. 
However, shortly after its publication, someone posted a 
high praise of the impact of the work on “Faculty of 1000” 
and gave this study the “Exceptional” ranking. The lack of 
citation sat well with us because it confirmed the novelty of 
our study and the lack of competition. The interest on this 
subject has certainly grown in the past decade as both the 
citation and views of this paper has steadily increased.  
3  Impacts of monomethyl branched-chain fatty 
acids on cell signaling and postembryonic growth 
control—the TORC1 connection 
The reversibility of the developmental arrest raised the pos-
sibility that these FA variants, or more complex lipids con-
taining them, may play a “regulatory” role in growth and 
development. This speculation became a plausible hypothe-
sis after Marina published the second paper on mmBCFAs 
in 2008 with the following observations [56]. First, using 
several markers, we observed that the L1 arrest phenotype 
was fully penetrant and within a few hours after hatching, 
halting most, if not all, postembryonic divisions and differ-
entiation. Second, the L1 arrest was similar to starva-
tion-induced L1 arrest (L1 diapause) that was known to be 
regulated by the insulin/insulin-like growth factor signaling 
(IIS) pathway [57–59]. Third, the growth response of the 
arrested animals to a gradient of supplemental mmBCFA 
concentrations was nonlinear; the dosage response was 
nearly all-or-none. In addition, the amount of mmBCFA 
supplement sufficient to reverse the L1 arrest was also suf-
ficient to provide normal reproductive growth. Fourth, 
mmBCFAs repressed cyclin-dependent kinase inhibitor 
CKI-1 that was known to inhibit cell division and growth 
during postembryonic development [58,60]. Finally, 
mmBCFAs appeared to function in a mechanism that was in 
parallel to the IIS pathway that mediates the food-sensing 
pathway. Although none of these observations provided 
definitive evidence for a regulatory role of mmBCFAs, they 
were collectively sufficient for the lab to commit to a seri-
ous chase for such a role. This 2008 paper also described a 
simple feedback loop that involves transcription factors 
SREBP and CBP in regulating mmBCFA homeostasis [56].  
There are two possible explanations for why mmBCFA- 
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deficient worms robustly halt their postembryonic devel-
opment. One simple possibility is that mmBCFAs have 
structural functions that are absolutely essential for the ex-
ecution of cell division, growth and differentiation. Alterna-
tively, mmBCFAs or lipids containing them act to facilitate 
or promote a regulatory system that “turns off” postembry-
onic development when it senses the deficiency of these 
lipids. If the later hypothesis would be correct, we might be 
able to generate a genetic mutation that would constitutively 
activate the regulator or sensor (flipping the switch on) and 
force the worms to continue to develop without these spe-
cial FAs. Experimentally, we could just mutagenize elo-5(-) 
mutants growing on food without mmBCFA supplement 
and screen for rare suppressors that permit worms to grow 
past L1 stage.   
Four researchers in the lab, two graduate students and 
two postdoctoral fellows, made sequential runs at this tech-
nically challenging suppressor search with variations in 
screen designs. From independent screens, Emylie Seamen 
and Jen Blanchette isolated three promising suppressors that 
permitted elo-5(-) mutants to grow for one generation 
without altering mmBCFA biosynthesis or absorption [61]. 
Subsequent mapping and cloning showed that all three of 
them are alleles of the same gene encoding a P-type 
ATPase/flippase (TAT-2) that likely acts to translocate spe-
cific lipids in the lipid bilayer or between different orga-
nelles [62,63]. Their further analysis suggested that the role 
of mmBCFAs on postembryonic growth may be mediated 
by mmBCFA-containing sphingolipids and that TAT-2 an-
tagonizes this function in intestinal cells, possibly by mov-
ing the lipids to different locations [61]. Mutating TAT-2 
would increase the local concentration of these lipids at the 
intestinal membrane and permit the worms to continue to 
develop under the condition that mmBCFA de novo synthe-
sis is shut down. Rencheng Wang performed another screen 
and isolated several effective suppressors as well. Interest-
ingly, none were alleles of tat-2 and all seemed to partially 
recover mmBCFA levels, which was interesting to investi-
gate for a different reason. He mapped and cloned two 
genes and focused his further study on prx-5 that encodes an 
ortholog of the human receptor for the type-1 peroxisomal 
targeting signal protein. His study indicated that compro-
mising peroxisomal protein import likely reduced peroxi-
some-involved degradation of mmBCFAs, at least in part 
through a -oxidation-independent mechanism [64]. 
Since neither TAT-2 nor PRX-5 was part of the hypo-
thetical regulatory system, Zhu Huanhu, a new postdoctoral 
fellow, continued the suppressor screen effort in 2009. 
Among the suppressors he isolated, one appeared to be the 
one we had chased all along: this mutation permitted the 
elo-5(-) worms to grow for indefinite generations without 
recovering mmBCFA biosynthesis. These suppressed 
worms were very unhealthy and grew slowly, which was 
totally expected given the likely diverse roles of these lipids 
and the gene defined by the suppressor. He position cloned 
the suppressor gene and showed it encodes a homolog of the 
NPRL3 family protein, which instantly implicated a con-
nection to the TORC1 signaling pathway because previous 
genetic work in yeast had indicated a repressive role of the 
NPR2/NPR3 complex on TOR [65]. Huanhu then made 
three transgenes, following the published schemes used in 
mammal cell cultures [66–68], to show that activation of 
TORC1 allowed mmBCFA deficient animals to bypass L1 
arrest (Figure 2) [69]. In addition, the suppression by the 
nprl-3(-) mutation can be reversed by reducing TORC1 ac-
tivity. We concluded that mmBCFAs promote TORC1 ac-
tivity that controls postembryonic development.  
Ironically, the lab had suspected the role of TOR-related 
pathways in mmBCFA-function several years prior; a post-
doc even wrote an NIH fellowship on testing TORC1 func-
tions. However, those early efforts, mostly relying on mak-
ing transgenes and applying RNAi, did not reveal the con-
nection. Indeed, the suppression effect by this nprl-3(ku340) 
mutation is far more robust than any of the hyper-TORC1 
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Figure 2 (color online)  A simplified model of how mmBCFA biosynthe-
sis impacts TORC1 signaling, postembryonic growth and development, 
and foraging behavior in C. elegans. Each green arrow represents multiple 
enzymatic reaction steps in the biosynthesis pathway [56,69,76,94]. Each 
blue arrow may not mean direct actions in regulation. Loss of NPRL-3 
activates TORC1 and also partially restores apical polarity in the absence 
of mmBCFAs. The latter effect could be due to a potential role of NPRL-3 
on apical polarity or a potential role of TORC1 in promoting apical polarity 
(see text for discussion). mmBCFAs: monomethyl branched-chain fatty 
acids. GlcCer: glucosylceramide. SPT and CGT denote palmitoyltrasferas-
es and ceramide glucosyltransferases, respectively. Only a few selected 
proteins among all acting in this circuit are indicated in this simplified 
scheme.  
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of doing chemical mutagenesis and the modifier screen. 
In Huanhu’s 2013 paper, we also described a brute force 
effort to identify d17iso-glucosylceramide as the high-order 
lipid that mediated the role of mmBCFAs on TORC1 sig-
naling, following the suggestion from our earlier study on 
TAT-2 [61]. Mass spec and other biochemical methods 
were effective arsenals in this study. For example, to prove 
mmBCFA-containing sphingosine is an intermediate in the 
pathway, Huanhu and another postdoctoral fellow Shen 
Huali, an analytical chemist with experience in mass spec-
trometry, had to purify this special lipid from a special bac-
terial strain using mass spectrometry as the readout. Addi-
tionally, they also had this lipid chemically synthesized. 
Huali also analyzed the lipid profile of elo-5(-);nprl-3(-) 
mutants to make sure that d17iso-glucosylceramide was not 
present in the suppressor strain, which helped to solidify the 
proposal that these lipids, mmBCFAs and d17iso- 
glucosylceramide, are not absolutely essential for develop-
ment, but only when TORC1 is activated by the nprl-3 mu-
tation (Figure 2).  
An obvious question for further study was how these li-
pids actually promote the activity of TORC1. TORC1 is 
known as a “hub” that senses the levels of multiple nutrients 
and metabolites, including amino acids, growth factors and 
energy, for diverse physiological functions [70]. Some 
“sensing” tasks are mediated by other signaling pathways. 
For example, the impacts of glucose, growth factors and 
energy level on TORC1 are mediated by IIS, TSC/Rhb and 
AMPK pathways [70,71]. Mechanisms of TORC1 activa-
tion by amino acids are less clear and appear to be inde-
pendent of these known signaling pathways [70,71]. More-
over, different mechanisms may be involved in the activa-
tion of TORC1 by different amino acids [72,73]. Far less 
has been learned about the roles of lipids on TORC1. Be-
cause branched-chain amino acids (leucine, isoleucine and 
valine) are precursors of mmBCFA biosynthesis [48,74,75], 
there is potentially an interesting connection between stud-
ies on these two types of nutrients. Additionally, leucine 
happens to be the precursor of C. elegans mmBCFA and the 
most extensively analyzed amino acid for TORC1 activa-
tion.  
Aileen Sewell and Zhu Huanhu carried out a multi-assay 
screen to identify potential factors that mediate the impact 
of d17iso-glucosylceramide on TORC1 [76]. They identi-
fied a number of genes that have known functions in regu-
lating membrane polarity. They found that mmBCFA defi-
ciency disrupted apical membrane polarity in the intestine, 
which confirmed the previous findings from Verena Go-
bel’s lab that sphingolipid biosynthesis is required for C. 
elegans intestinal apical membrane polarity [20,77]. Further 
analysis led to the conclusion that clathrin/AP-1 dependent 
intestinal apical membrane polarity regulates apical locali-
zation of the V-ATPase and other proteins that, in turn, af-
fect intestinal TORC1 activation (Figure 2) [76]. One sur-
prising observation was that apical polarity of mmBCFA 
deficient animals was dramatically improved by the addi-
tion of the nprl-3(-) mutation and the apical localization 
defect of the V-ATPase was also significantly suppressed. 
Additionally, the nprl-3 mutation could also partially sup-
press the developmental defects caused by knocking down 
clathrin and AP-1. These data may suggest that NPRL-3 has 
a role in regulating apical membrane polarity, which would 
point to a novel mechanism by which the NPRL-2/3 com-
plex represses TORC1, as such a mechanism is distinct 
from the reported role of the NPRL2/3 complex as a GAP 
protein to regulate RagA/B in mammalian cell lines and 
yeast [78,79]. Alternatively, the suppression of the apical 
polarity defects by nprl-3(-) could be due to a role of 
TORC1 in promoting apical polarity (Figure 2). Such a role 
of TORC1 would not be essential in wild type since dis-
rupting TORC1 does not cause apical polarity defects [76]. 
It might be important to note that our finding was based on 
analysis of a specific tissue (intestine) for specific physio-
logical roles (development) in animals, unlike the condi-
tions in the mammalian cell and yeast studies. The func-
tional relationships between membrane polarity, TORC1 
and NPRL-2/3 need to be tested in other organisms. Huanhu 
will surely make more advances in this area in his own new 
lab in Shanghai. 
These findings suggested that the TORC1 signaling sys-
tem not only sensed the level of certain nutrients through 
various vehicles, it also sensed the integrity of metabolic 
pathways and their regulated specific membrane dynamics. 
These studies on mmBCFAs and glucosylceramides also 
presented an outstanding example for how lipid variants 
impact specific signal transduction pathways. However, the 
mechanisms by which the actual difference in the FA struc-
ture, the little methyl side chain in the case of mmBCFA, 
affects the membrane properties remains a fascinating ques-
tion. In 2012, Marina and Huali published a seminal paper 
that tackled such a question while uncovering the role of 
mmBCFAs on another specific cell signaling event, IP3 
signaling in the zygote [80].  
4  Impact of mmBCFAs on cell signaling and 
embryogenesis—the IP3 connection  
A free FA needs to be “activated” by an acyl-coA synthe-
tase (ACS) to become a fatty acyl-CoA before engaging in 
further metabolic reactions such as elongation, degradation, 
incorporation into a high-order lipid, or lipidation of pro-
teins [81,82]. The ACS enzymes belong to a large protein 
family, with more than 20 members in mammals and alter-
native splicing could potentially generate even more  
variants, which may suggest that ACSs play important  
roles in facilitating specific functions associated FA  
variants [81,83,84]. First, specific ACSs may only use spe-
cific types of FAs as substrates. Second, if the esterification 
of FAs by ACSs is coupled with further reactions, an ACS 
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could potentially also specify the fate of particular FAs. 
Finally, different ACS genes may also be differentially ex-
pressed in different tissue and at different times during de-
velopment. Several ACS enzymes have been studied exten-
sively in mammals, connecting to specific physiological 
functions (e.g, [84]).  
An mmBCFA specific ACS in C. elegans, ACS-1, was 
discovered by Marina in her search for the feedback regula-
tory loop for mmBCFA homeostasis [48,56]. ACS-1 is re-
quired for the biosynthesis of C17iso and the ability of free, 
dietary mmBCFAs to rescue the growth of elo-5(-) animals. 
However, Marina observed a fully penetrant early embry-
onic lethality associated with the acs-1(-) mutant, but only 
did so when she fed the mutant with certain levels of dietary 
C17iso [80]. More specifically, all the membrane dynamics 
of the zygote and early embryo, including exocytosis and 
cytokinesis, were disrupted. Two questions were immedi-
ately raised about the mechanism underlying the spectacular 
phenotypes: what caused the membrane defects and what 
did the mmBCFAs do to the lipids in the absence of 
ACS-1?  
Our previous experience with suppressor analysis served 
us well here in finding out that the major membrane defect 
in the early embryo was mainly due to the failure of IP3 
signaling that regulates cellular Ca2+ level. Marina found 
that mutations that hype-activate IP3 receptor or raise IP3 
levels [85–88] can suppress much of the early embryonic 
defects and, conversely, RNAi knockdown of the IP3 re-
ceptor produced an embryonic phenotype similar to that of 
acs-1(-) with C17iso supplementation. The role of IP3 sig-
naling in regulating exocytosis and cytokinesis is consistent 
with studies in vertebrate animals [89–91]. This again 
linked mmBCFA metabolism to a specific signaling event, 
but by a very different mechanism (Figure 3).  
Huali devoted a huge effort to the identification of spe-
cific changes in lipid composition using mass spec, while 
Marina used several genetic tools to determine that ACS-1 
needs only to be expressed in the somatic sheath cells for 
this function. The combination of these analyses led to a 
model where C17iso is incorporated into phosphatidyleth-
anolamine (PE) in the somatic gonad in an ACS-1 depend-
ent manner, while C17iso is also incorporated into a novel 
phospholipid (PL) in an ACS-1-independent manner. These 
lipids with proper balance are transported into the oocytes 
and then zygotes to support proper membrane functions. In 
the absence of ACS-1 but with the C17iso supplement, 
C17iso is incorporated into this novel type of PL but not PE, 
creating the imbalance of PL composition or the dominant 
presence of this novel PL that is detrimental to the zygote. 
This novel PL, of which the structure had been extensively 
analyzed by a graduate student but not yet published, was 
only detected in the embryo, not in adult worms. Therefore, 
ACS-1, an enzyme that adds CoA to an mmBCFA, “regu-
lates” the PL composition in the zygote by somehow chan-
neling this FA to a subgroup of PL in the somatic gonad that  
 
Figure 3 (color online)  Model of how acyl-coA synthetase activities on 
mmBCFAs impact lipid composition and a specific signaling event (IP3) in 
a specific tissue (zygote) [80]. mmBCFAs are synthesized or obtained from 
diet in the intestine. They are incorporated into certain classes of phospho-
lipids (PL) requiring specific ACS enzymes. ACS-1, acting in de novo 
synthesis of mmBCFAs in the intestine, is also required for channeling 
mmBCFAs into phosphatidylethanolamine (PE) and related PLs in the 
somatic gonad that wrap around the germ cells. However, mmBCFAs are 
also incorporated into a different class of PL (referred to as PN, see text) in 
a ACS-1-independent manner, suggesting the involvement of one or more 
other ACS enzymes (ACS-X) in the step. In wild type, C17iso-PE and 
C17iso-PN, in a proper ratio, enter oocytes and critically contribute to the 
proper lipid composition in the zygote. Such lipid composition, likely 
unique to the zygote, is essential for IP3 signaling that regulates exocytosis 
and membrane dynamics during early embryogenesis. When ACS-1 function 
is lost in the somatic gonad, C17iso-PE, but not C17iso-PN, dramatically 
decreases, leading to imbalanced lipid composition in the zygote and com-
plete disruption of membrane ruffling, cytokinesis and other cellular process-
es. These defects can be suppressed by hyper-activating IP3 signaling.  
wraps around the germline (Figure 3). How the earlier reac-
tion (ACS action on FA) dictates the specificity of the later 
reaction (incorporation of FA-CoA to a PL by a transferase) 
is unknown and a very challenging question that is too dif-
ficult to address for multiple reasons. The results from this 
study may perhaps imply a more important message: the 
little methyl branch in mmBCFAs might not have any 
meaningful structural function in the PLs; the specificity of 
the mmBCFA-ACS-1 interaction may simply allow the 
animals to manipulate or alter PL compositions in a specific 
tissue for a specific cell signaling event.  
I considered this 2012 paper, published in Genes Dev 
with a review [80] and a cover illustration, to be one the 
best papers I have ever authored and it significantly en-
hanced our chances to get my HHMI investigator appoint-
ment renewed one more time in 2012. Besides the scientific 
significance and complexity of the study, I also love the fact 
that it took us three years from our first journal submission 
to its final publication. In these three years while we revised 
the manuscript for multiple rounds of submission to Sci-
ence, Cell and Dev Cell, before sending it to Genes Dev, we 
benefited tremendously, not only about improving our 
presentation and experimental support, but also in under-
standing the significance of our own data and working in 
the lipid field in general. The lessons we learned were 
sometimes from the suggestions by reviewers, but more 
often by seeing the misunderstanding by the editors and 
reviewers. Our initial draft, that focused too much on the  
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cytokinesis defects rather than the key issues I mentioned 
above, was quite naïve. The reviewers tended to treat it as a 
cell biology paper. The manuscript progressively got better 
as we became wiser and more realistic about working and 
publishing in the field. We also learned that it is generally 
very difficult to get editors and reviewers to fully appreciate 
such an interdisciplinary study in this rather “cold” lipid 
field. One difficulty seemed to be finding reviewers who 
had the diversified expertise and desire to evaluate this 
study, that used both extensive mass spec analysis of lipids 
and sophisticated genetics to address a metabolic problem 
with developmental phenotypes.  
5  The impact of lipid metabolism on foraging 
behavior  
Lipid metabolism has been shown in limited studies to  
impact animal behaviors including food responses  
(e.g., [92,93]). Our lab also made a significant contribution 
in this regard by discovering the role of the mmBCFA/ 
d17iso-glucosylCeramide/TORC1 pathway in foraging be-
havior [94]. Marina noticed a few years ago that 
mmBCFA-deficient L1 larvae failed to locate food and 
much of this failure was due to defects in dwelling behav-
ior. This defect was not associated with L1 larvae arrested 
due to food deprivation (L1 diapause). She then determined 
that mmBCFAs are required for proper expression of a 
transcription factor in the neurons that in turn regulates dif-
ferentiation or maturation of certain sensory neurons that 
contribute to the defect in food seeking. Huanhu and Aileen 
found that this mmBCFA-dependent foraging behavior is 
also mediated by glucosylceramide and at least in part by 
TORC1 in the intestine (Figure 2) [94]. What is the physio-
logical significance of a lipid biosynthesis pathway and 
TORC1 signaling in the gut having such a profound impact 
on food seeking responses? During starvation, when growth 
and development are mostly suppressed by changes in certain 
regulatory systems, animals must continue to develop their 
neuronal systems to maintain or enhance food-seeking  
ability [95,96]. Lipids, which are more stable than some 
other nutrients or metabolites under starvation, may pro-
mote neuronal functions. This study also suggested that the 
intestine plays a critical role in the dwelling behavior; the 
quality of the food is accessed by a signaling mechanism in 
the intestine that requires the mmBCFA biosynthesis path-
way. How do the activities of these lipids and TORC1 in the 
intestine impact transcription factors and other factors in the 
neuron for this behavior is an attractive question to pursue 
further. Genome-wide expression analysis [94] and a sys-
tematic genetic screen (unpublished) are the first few steps 
to address this question. 
6  Closing remarks 
In today’s research environment, moving to a new field 
where you do not have expertise and connections is ex-
pected to be difficult, especially for a small or modest size 
laboratory like ours. Getting your papers published in good 
places and earning good scores on your grants could be 
even bigger obstacles than actually doing the work. Our 
positive experience, if considered to be successful, may be 
attributed to two other key factors: (i) the lab has been sup-
ported since 1997 by HHMI that encourages risk taking, 
funds people rather than specific projects, and cares rela-
tively less about whether you have published in certain 
journals; and (ii) the lab researchers are encouraged to work 
independently and follow their own ideas. The upside of (ii) 
might not seem to be as obvious as that of (i). In my opin-
ion, the ability of students and postdoctoral fellows to take 
on projects in unfamiliar territories is far greater than most 
PIs realize. This “hands-off” style of supervision should not 
simply be criticized for providing a weak training environ-
ment, as has often been commented in NIH postdoctoral 
training grant review sessions. As you may have sensed 
from reading above, the vast majority of new research di-
rections, including our studies on lipids, KASH-SUN com-
plexes, miRNAs, and genetic redundancy, were initiated by 
students and postdoctoral fellows, and in a couple of cases 
against my initial suggestions. In fact, newcomers often 
prefer to work on new directions or to perform screens that 
have the potential to identify novel things. Furthermore, 
postdoctoral fellows are encouraged to take the projects 
they worked on to their own lab, when they obtain an inde-
pendent research position.  
While our research style may not be suited for or valued 
by too many PIs, we will continue to have fun exploring 
new and interesting questions, some of which will be in 
areas we were not familiar with. For example, two postdoc-
toral fellows are leading the effort in two new and underex-
plored directions: uncovering and characterizing cellular 
regulatory systems that connect changes in nucleotide levels 
to development and that connect lipid metabolism to germ 
cell development.  
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